Illumina, Inc.

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis. The company offers instruments and consumables, including reagents, flow cells, and library preparation products. Its product portfolio includes whole-genome sequencing kits, designed to sequence entire genomes of varying sizes and complexities, and targeted resequencing kits, which sequence exomes, specific genes, RNA, or other genomic regions of interest. Illumina also provides services such as whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support. The company serves a diverse customer base, including genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical companies, biotechnology firms, commercial molecular diagnostic laboratories, and consumer genomics companies. Illumina markets and distributes its products directly to customers and through life-science distributors across the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company collaborates with Labcorp Holdings Inc. to develop oncology treatments using sequencing solutions and has a data partnership with the Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare diseases. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.